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984catheter (St. Jude Medical, Westford, Massachusetts).
OCT demonstrated high-intensity superﬁcial regions
of the intimal tissue with intensity attenuation (not
stent strut) after DEB dilation (Figures 1D to 1I).
The high-intensity superﬁcial regions are thought
to represent an iopromide/paclitaxel mixture because
SeQuent Please uses the contrast medium iopromide
to separate and evenly distribute paclitaxel molecules
over the surface of the balloon.
After the PCI procedure, we assessed whether the
contrastmedia could be visualized byOCT in an in vitro
setting using the same system. We performed OCT on
a surgical grove that was wet with contrast medium
iomeprol, with a glove with dried contrast medium on
the surface, and a glove without contrast medium.
We conﬁrmed similar high-intensity superﬁcial
regions due to dry contrast medium smeared on the
surgical glove visualized by OCT. However, we could
not visualize high-intensity superﬁcial regions with
wet contrast medium or without contrast media.
Further studies are required to determine whether
these areas do indeed represent iopromide and/or
paclitaxel because we do not know with certainty the
composition of the high-intensity regions.Tsubasa Sakamoto, MD
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Active Reversible Disease in Human
Breast ArteriesMedial arterial calciﬁcation (MAC) is currently gaining
interest as a possible cause of cardiovascular diseasedistinct from atherosclerosis (1). Because MAC is
actively regulated by processes bearing great
similarities to the dynamic process of bone
formation, reversibility of MAC can be expected (1).
Although regression has been observed in animal
models, surprisingly limited observations of MAC
regression in humans are available. Currently none
of the cardiovascular medications has convincingly
been shown to modify arterial calciﬁcation.
Breast arterial calciﬁcation (BAC) is a type of MAC
regularly observed in mammography. In breast cancer
screening programs, these arteries are visualized re-
peatedly in a highly systematic fashion in the general
population. BAC can therefore serve as a convenient
model for MAC. BAC was found to be independently
associated with amoderately increased cardiovascular
disease risk in the general population (2). A few cases of
BAC regression have been reported (3). The extent to
which BAC regression occurs remains unknown.
We hypothesized that BAC regression would be
present in a population of women participating in
breast cancer screening. From August 1, 1998, to
January 31, 1999, we screened 32,589 women by
mammography within the Utrecht area in the
Netherlands. After approval was obtained from the
institutional review board of the University Medical
Center Utrecht, the mammograms of these women
were systematically investigated for BAC by 1 of 2
board-certiﬁed radiologists. If BAC was present, the
index mammogram was retrospectively compared
with previous mammograms, if available. Regression
was deﬁned as a decrease of arterial calciﬁcation
in at least 1 segment of an artery compared with
previous mammograms, as illustrated in Figure 1. To
determine whether regression had occurred, both
radiologists assessed the mammograms and resolved
disagreements in consensus meetings.
At least 1 previous mammogram was available for
25,296 women; of these, 2,948 (11.8%) had BAC in at
least 1 breast on the index mammogram. Among these
2,948 women with BAC, the BAC had regressed in
98 women (3.3%; 95% conﬁdence interval: 2.7 to 4.0).
All women with regression of BAC were sent a ques-
tionnaire regarding their medical history and cardio-
vascular risk factors. The 43 women (44%) who
completed the questionnaire were on average 72.5
years of age with a body mass index of 25.5 kg/m2.
Cardiovascular risk factors were common: 34.9% cur-
rent or previous smokers, 37.2% with hypertension,
36.6% with hypercholesterolemia, 14.6% with dia-
betes, and 11.9%with renal disease. Although no direct
comparison is possible, the characteristics of these
women appear comparable to those of women with
BAC described in published reports (2). Regression of
FIGURE 1 Regression of Breast Artery Calciﬁcation
Two mammograms taken 4 years apart, showing regression of breast artery calciﬁcation.
J A C C : C A R D I O V A S C U L A R I M A G I N G , V O L . 8 , N O . 8 , 2 0 1 5 Letters to the Editor
A U G U S T 2 0 1 5 : 9 8 3 – 9
985BAC has been reported to occur after renal transplant,
but this cannot fully explain our ﬁndings (3). The
dual assessment of mammograms with BAC re-
gression has diminished measurement error due to
interrater variability; however, some measurement
error may remain, due to between-mammogram
variability. Most of the regression found, however,
represented clear interruptions in chains of calcium
that were previously not interrupted, which was easy
to ascertain.
In conclusion, our study convincingly showed that
MAC is a reversible process in the population. Further
research into the causes of regression and possible
effective therapy is warranted.Eva J.E. Hendriks, MD*
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A Heart Stressed Out of Energy?Tako-tsubo cardiomyopathy (TTC) is an acute form
of left ventricular (LV) systolic dysfunction often
following intense stress, but its pathophysiology
remains elusive. Because of its reversible natural
course without much apparent myocyte damage, as
inferred by the lack of late gadolinium-enhanced
(LGE) cardiac magnetic resonance (CMR), it has been
a priori assumed that its evolution is benign (1).
Whatever the etiology of the acute insult, it is
important to establish the nature of this state of
intense myocardial contractile dysfunction with
preserved viability, as this may point to a potential
therapeutic target in those cases with a less favorable
clinical course. It is known that impaired cardiac
energetic status is directly linked to clinical and
subclinical LV dysfunction. We hypothesized that
impaired cardiac energetics may occur in acute
